The Stratify Prostate executive committee is made up of leading physician-scientists committed to advancing precision medicine for men with metastatic prostate cancer. 

 
 
Eric_small.jpg

Eric Small, MD

Professor of Medicine and Chief, Division of Hematology/Oncology, University of California, San Francisco; Deputy Director and Prostate Cancer Program Leader, UCSF Helen Diller Family Comprehensive Cancer Center

 
 
Keith.jpg

Keith Flaherty, MD

Professor, Harvard Medical School; Director of Developmental Therapeutics Program, Massachusetts General;  Principal Investigator, NCI-MATCH; Co-founder and Chair, Clinical Advisory Board, Strata Oncology, Inc.

 
 
Felix_Feng.jpg

Felix Feng, MD

Associate Professor of Radiation Oncology and Urology, Vice Chair for Faculty Development and Director of Translational Research, Department of Radiation Oncology, University of California, San Francisco

 
 
Scott_Tomlins.jpg

Scott Tomlins, MD, PhD 

Associate Professor, Pathology and Urology, University of Michigan Medical School; Michigan Center for Translational Pathology; Co-founder and Laboratory Director, Strata Oncology, Inc.